| Dr Steven Allen Fiamengo, MD | |
|
300 W. Hospital Road, Eisenhower Army Medical Center, Attn, Credentials, Fort Gordon, GA 30905-5650 | |
| (706) 787-2720 | |
| (706) 787-8176 |
| Full Name | Dr Steven Allen Fiamengo |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 44 Years |
| Location | 300 W. Hospital Road, Eisenhower Army Medical Center, Fort Gordon, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184786386 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 054241 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Coliseum Medical Centers, Llc, Dba | Macon, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Piedmont Anesthesia Llc | 2163837972 | 155 |
News Archive
A number of behaviors in younger adults that increase risk for the transmission of HIV/AIDS have declined or changed between 2010 and 2020, according to the national Monitoring the Future study.
A new classification system that scores the variables associated with mortality rates for patients who develop intra-abdominal sepsis after surgery may help guide care and improve outcomes
An international study in which Javier Belda, Professor of Surgery at the University of Valencia and Incliva researcher, participated, has identified a new genetic variant associated with Acute Respiratory Distress Syndrome.
Pharmaceuticals, Inc. today announced interim results of a randomized, open‐label, active-control multicenter Phase 2 study of oral ridaforolimus, an investigational mTOR inhibitor, in patients with metastatic or recurrent endometrial cancer. Based on this interim analysis, the study demonstrated a statistically significant improvement in the primary endpoint of median progression-free survival (PFS) in patients receiving single-agent ridaforolimus compared to patients receiving standard-of-care treatment.
Researchers at Columbia University have developed COVID-19 Trial Finder, a simplified method for patients, clinicians and healthy volunteers to search for appropriate COVID-related clinical trials in their general location.
› Verified 6 days ago
| Entity Name | Peach State Anesthesia Partners, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134751191 PECOS PAC ID: 8527496777 Enrollment ID: O20200321000409 |
News Archive
A number of behaviors in younger adults that increase risk for the transmission of HIV/AIDS have declined or changed between 2010 and 2020, according to the national Monitoring the Future study.
A new classification system that scores the variables associated with mortality rates for patients who develop intra-abdominal sepsis after surgery may help guide care and improve outcomes
An international study in which Javier Belda, Professor of Surgery at the University of Valencia and Incliva researcher, participated, has identified a new genetic variant associated with Acute Respiratory Distress Syndrome.
Pharmaceuticals, Inc. today announced interim results of a randomized, open‐label, active-control multicenter Phase 2 study of oral ridaforolimus, an investigational mTOR inhibitor, in patients with metastatic or recurrent endometrial cancer. Based on this interim analysis, the study demonstrated a statistically significant improvement in the primary endpoint of median progression-free survival (PFS) in patients receiving single-agent ridaforolimus compared to patients receiving standard-of-care treatment.
Researchers at Columbia University have developed COVID-19 Trial Finder, a simplified method for patients, clinicians and healthy volunteers to search for appropriate COVID-related clinical trials in their general location.
› Verified 6 days ago
| Entity Name | Piedmont Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700474244 PECOS PAC ID: 2163837972 Enrollment ID: O20210208002823 |
News Archive
A number of behaviors in younger adults that increase risk for the transmission of HIV/AIDS have declined or changed between 2010 and 2020, according to the national Monitoring the Future study.
A new classification system that scores the variables associated with mortality rates for patients who develop intra-abdominal sepsis after surgery may help guide care and improve outcomes
An international study in which Javier Belda, Professor of Surgery at the University of Valencia and Incliva researcher, participated, has identified a new genetic variant associated with Acute Respiratory Distress Syndrome.
Pharmaceuticals, Inc. today announced interim results of a randomized, open‐label, active-control multicenter Phase 2 study of oral ridaforolimus, an investigational mTOR inhibitor, in patients with metastatic or recurrent endometrial cancer. Based on this interim analysis, the study demonstrated a statistically significant improvement in the primary endpoint of median progression-free survival (PFS) in patients receiving single-agent ridaforolimus compared to patients receiving standard-of-care treatment.
Researchers at Columbia University have developed COVID-19 Trial Finder, a simplified method for patients, clinicians and healthy volunteers to search for appropriate COVID-related clinical trials in their general location.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Steven Allen Fiamengo, MD 300 W. Hospital Road, Eisenhower Army Medical Center, Attn, Credentials, Fort Gordon, GA 30905-5650 Ph: (706) 787-2720 | Dr Steven Allen Fiamengo, MD 300 W. Hospital Road, Eisenhower Army Medical Center, Attn, Credentials, Fort Gordon, GA 30905-5650 Ph: (706) 787-2720 |
News Archive
A number of behaviors in younger adults that increase risk for the transmission of HIV/AIDS have declined or changed between 2010 and 2020, according to the national Monitoring the Future study.
A new classification system that scores the variables associated with mortality rates for patients who develop intra-abdominal sepsis after surgery may help guide care and improve outcomes
An international study in which Javier Belda, Professor of Surgery at the University of Valencia and Incliva researcher, participated, has identified a new genetic variant associated with Acute Respiratory Distress Syndrome.
Pharmaceuticals, Inc. today announced interim results of a randomized, open‐label, active-control multicenter Phase 2 study of oral ridaforolimus, an investigational mTOR inhibitor, in patients with metastatic or recurrent endometrial cancer. Based on this interim analysis, the study demonstrated a statistically significant improvement in the primary endpoint of median progression-free survival (PFS) in patients receiving single-agent ridaforolimus compared to patients receiving standard-of-care treatment.
Researchers at Columbia University have developed COVID-19 Trial Finder, a simplified method for patients, clinicians and healthy volunteers to search for appropriate COVID-related clinical trials in their general location.
› Verified 6 days ago
Tracy L Eichel, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 300 W Hospital Rd, Eisenhower Army Medical Center Credentials, Fort Gordon, GA 30905 Phone: 706-787-5915 Fax: 706-787-8176 | |
Austin Bell, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 300 E. Hospital Road, Fort Gordon, GA 30905 Phone: 858-334-5328 | |
Dr. Rodica Balazs, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: Building 300, Dwight D. Eisenhower Army Medical Center, Fort Gordon, GA 30905 Phone: 706-787-5811 | |
Dr. Rebecca Ann Keller, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: Hospital Road, Fort Gordon, GA 30905 Phone: 706-787-1910 |